Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

ImmunoForge gets rights to PB1023 from PhaseBio

April 19, 2019 5:13 PM UTC

PhaseBio granted ImmunoForge exclusive, worldwide rights to develop and commercialize PB1023 for all indications except diabetes, obesity and non-alcoholic steatohepatitis (NASH).

ImmunoForge Co. Ltd. (Seoul, South Korea) will develop the compound for serious sarcopenia-related diseases...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

PhaseBio Pharmaceuticals Inc.